nontuberculous%20mycobacterial%20disease
NONTUBERCULOUS MYCOBACTERIAL DISEASE
Nontuberculous mycobacteria are ubiquitous and are usually found in soil, natural and treated water sources. They are relatively uncommon cause of pulmonary disease and likely to cause disseminated disease.
May cause both asymptomatic infection and symptomatic disease in humans.
There is no evidence of animal-to-human or human-to-human transmission in immunocompetent hosts.
Nontuberculous mycobacterial pulmonary disease is a generally slowly progressive infection.
Signs and symptoms are generally nonspecific.

Introduction

  • Nontuberculous mycobacterial (NTM) pulmonary diseases are ubiquitous & are usually found in soil, natural & treated water sources
    • Relatively uncommon cause of pulmonary disease
    • Likely to cause disseminated disease except Mycobacterium kansasii which causes lung infection w/o dissemination among HIV-coinfected patients w/ low CD4 counts
  • May cause both asymptomatic infection & symptomatic disease in humans
  • There is no evidence of animal-to-human or human-to-human transmission in immunocompetent hosts
  • NTM pulmonary disease is a generally slowly progressive infection

Etiology

  • M avium complex (MAC) is the most common NTM species causing pulmonary disease in the US
    • Includes at least 2 mycobacterial species: M avium & M intracellulare
    • M intracellulare is the more common respiratory pathogen
    • Commonly found in indoor water systems, pools & hot tubs
  • M kansasii & M abscessus are the 2nd & 3rd most common pulmonary pathogen, respectively

Signs and Symptoms

  • Generally nonspecific
  • Chronic or recurring cough w/ sputum production
  • Dyspnea, chest pain
  • Fatigue, malaise, weightt loss, fever, hemoptysis
  • May be complicated by symptoms caused by coexisting lung diseases

Risk Factors

  • Hot tub exposure
  • Older men who are smokers, older women w/ no smoking history
  • Excessive alcohol use
  • Co-existing illnesses: chronic obstructive pulmonary disease (COPD), cystic fibrosis, pneumoconiosis, prior tuberculosis (TB), esophageal motility disorders, pulmonary alveolar proteinosis, malignancy
  • There is an association between bronchiectasis, nodular NTM pulmonary disease & specific body type especially postmenopausal women (eg pectus excavatum, scoliosis, mitral valve prolapse, joint hypermobility)
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
22 May 2017
Chronic obstructive pulmonary disease (COPD) is currently the 10th commonest cause of death in Singapore, with a disease burden of 5.9 percent according to a 2015 population-based survey (EPIC-Asia survey) in Singapore. Pearl Toh spoke with Dr Augustine Tee, chief and senior consultant of the Department of Respiratory and Critical Care Medicine at Changi General Hospital (CGH) in Singapore, on how COPD is often underdetected in the primary care population as symptoms are not specific and diagnosis requires a combination of clinical risk factors, symptoms and spirometry testing.
15 Aug 2017
New drug applications approved by US FDA as of 1 - 15 August 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
04 Aug 2017
Chronic obstructive pulmonary disease (COPD) is the fourth cause of global mortality, with experts predicting a potential future rise in the prevalence rates of COPD. 
11 May 2016

In conjunction with World Asthma Day which falls on 3rd May 2016, MIMS Doctor speaks to a renowned respiratory medicine specialist, Dato' Dr. Hj Abdul Razak Abdul Muttalif, regarding the chronic airway disease.